Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instituto do Coração (InCor) is one of the largest and most advanced cardiology hospitals in Latin America, specializing in high-complexity cardiovascular and cardiothoracic care, research, and education. It is recognized for its expertise in coronary interventions, heart failure management, cardiac and lung transplants, cardio-oncology, and innovative diagnostic and therapeutic technologies. InCor is a national leader in clinical research, including multicenter studies on TTR amyloidosis, and is a pioneer in the development and deployment of advanced technologies such as RFID for hospital asset management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto do Coração.